Chemenon Pharma Private Limited
About Chemenon Pharma Private Limited
Data last updated:
Chemenon Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the real estate development and construction segment of the real estate and construction sector. It was incorporated on 22 October 1970 and has been in existence for over 56 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U70100MH1970PTC014852.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.95 Lakh. It is led by directors including Mehul Hemchand Gala and Ruchita Mahendra Gala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Behind Vakola Marketoff Nehru Road Santacruz East, Mumbai, Maharashtra, India – 400055.
As per MCA filings, the company has open charges of ₹45 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Chemenon Pharma has one previous CIN (Corporate Identification Number): U24239MH1970PTC014852. The current CIN is U70100MH1970PTC014852, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U70100MH1970PTC014852 | Current |
| U24239MH1970PTC014852 | Previous |
Contact details
Chemenon Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBehind Vakola Marketoff Nehru Road Santacruz East, Mumbai, Maharashtra, India – 400055
- IndustryReal Estate and Construction, Real Estate Builders & Developers
To see the full contact details of Chemenon Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Chemenon Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chemenon Pharma Private Limited, buy the company report.
Board of directors of Chemenon Pharma Private Limited
Chemenon Pharma has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mehul Hemchand Gala | Director | 26 Aug 2021 | 5 Years 1 Months | Current |
| Ruchita Mahendra Gala Also directs: Gold Coin Builders LLP | Director | 16 Jul 2018 | 8 Years 3 Months | Current |
| Mahendra Surji Gala | Director | 18 Jan 1989 | 37 Years 9 Months | Current |
| Monil Hemchand Gala | Director | 26 Aug 2021 | 5 Years 1 Months | Current |
Auditor
Chemenon Pharma Private Limited is audited by J.K. LAHOTI & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J.K. LAHOTI & CO. | FY 2022 | 016655 |
Shareholding
The shareholding of Chemenon Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Chemenon Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2024 | 101037867 | Others | ₹45 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Chemenon Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chemenon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Chemenon Pharma has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Chemenon Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Chemenon Pharma Private Limited has 10 board changes on record since 1989: 4 appointments and 6 cessations. The latest: Mehul Hemchand Gala ceased to be Additional Director on 30 Nov 2021.
2 earlier events are in the company report.
Frequently asked questions
Chemenon Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in real estate builders and developers, within the real estate and construction industry. It was incorporated on 22 October 1970 (56+ years old) and is registered under CIN U70100MH1970PTC014852.
Chemenon Pharma has 4 current directors:
- Mehul Hemchand Gala - Director
- Ruchita Mahendra Gala - Director
- Mahendra Surji Gala - Director
- Monil Hemchand Gala - Director
The latest financial statements of Chemenon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Chemenon Pharma is U70100MH1970PTC014852. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemenon Pharma was incorporated on 22 October 1970, making it 56+ years old. It is registered with the Registrar of Companies, Mumbai.
Mehul Hemchand Gala ceased to be Additional Director on 30 Nov 2021. Monil Hemchand Gala ceased to be Additional Director on 30 Nov 2021. Mehul Hemchand Gala was appointed as Director on 26 Aug 2021. Chemenon Pharma has 10 board changes on record in total.
The registered office of Chemenon Pharma is at Behind Vakola Marketoff Nehru Road Santacruz East, Mumbai, Maharashtra, India – 400055.
Chemenon Pharma operates in the real estate and construction industry, in the real estate builders and developers segment.
Chemenon Pharma has open charges of ₹45 Cr and no satisfied charges on record as per latest MCA filings.
The compliance status of Chemenon Pharma is compliant as of 11 July 2026. The company is actively filing with the Registrar of Companies.